FDA
-
-
-
-
-
-
-
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
-
-
-
-
-
-
-
Celularity’s Dr. Robert Hariri To Co-Chair The 2023 International Precision Medicine Center (IPMC) Conference “Beyond Longevity: Live 120 Like 50™”
-
-
-
-
-
-
-
Celularity Appoints Paul Graves as Chief Communications Officer
-
-
-
-
-
-
-
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/27: (MBOT) (LUCD) (CELU) Higher; (BBIO) (BVXV) (PSTI) Lower (more...)
-
-
-
-
-
-
-
Celularity Reports Second Quarter 2021 Financial Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

